Skip to main content

Diffuse Large B-Cell Lymphoma Resource Center

Diffuse Large B-Cell Lymphoma
Learning Library

New & Trending

EZH2
Rapid Refresh
02/28/2024
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role of EZH2 in the regulation of cell growth and the effects of EZH2 overexpression.
This animation explains the role...
02/28/2024
APP Institute Oncology
Oluwatobi Odetola, MD,
Conference Coverage
12/12/2023
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual...
12/12/2023
Oncology
From Oncology
Narendranath Epperla, MD, MS
Conference Coverage
12/11/2023
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting,...
12/11/2023
Oncology
From Oncology

Clinical Pearls

APP Perspectives

Lorinda Coombs
APP Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology

Conference Coverage

Oluwatobi Odetola, MD,
Conference Coverage
12/12/2023
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual Meeting in San Diego, Oluwatobi Odetola, MD, shared data from a phase 1b study that evaluated the safety and efficacy of nivolumab in combination with R-CHOP in high-risk DLBCL.
During the 2023 ASH Annual...
12/12/2023
Oncology
Narendranath Epperla, MD, MS
Conference Coverage
12/11/2023
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting, Narendranath Epperla, MD, MS, presented a retrospective cohort study analyzing the patterns and outcomes of treatment with tafasitamab among patients with R/R diffuse large B-cell lymphoma across racial and...
At the 2023 ASH Annual Meeting,...
12/11/2023
Oncology
Conference Coverage
11/14/2024
Conducting new patient visits via telehealth with advanced practice providers allows for quicker identification, assessment, and surveillance of patients with monoclonal gammopathy of undetermined significance at increased risk of developing...
Conducting new patient visits via telehealth with advanced practice providers allows for quicker identification, assessment, and surveillance of patients with monoclonal gammopathy of undetermined significance at increased risk of developing...
Conducting new patient visits...
11/14/2024
APP Institute Oncology
Conference Coverage
04/28/2024

Amber Denham

Amber Denham
Research highlights the importance of examining the mental health needs of caregivers of patients with myelodysplastic syndromes.
Research highlights the importance of examining the mental health needs of caregivers of patients with myelodysplastic syndromes.
Research highlights the...
04/28/2024
APP Institute Oncology
Conference Coverage
04/27/2024

Janelle Bradley

Janelle Bradley
Study findings validate the feasibility and usability of a mobile health application for tracking symptoms of chronic GVHD among patients who received an allogeneic stem cell transplant.
Study findings validate the feasibility and usability of a mobile health application for tracking symptoms of chronic GVHD among patients who received an allogeneic stem cell transplant.
Study findings validate the...
04/27/2024
APP Institute Oncology
Conference Coverage
04/26/2024

Gina Tomaine

Gina Tomaine
The DASH machine learning model demonstrated superior benefits in identifying deterioration among patients undergoing HCT, which has great potential to improve patient outcomes, according to data presented at ONS Annual Congress.
The DASH machine learning model demonstrated superior benefits in identifying deterioration among patients undergoing HCT, which has great potential to improve patient outcomes, according to data presented at ONS Annual Congress.
The DASH machine learning model...
04/26/2024
APP Institute Oncology
Conference Coverage
04/26/2024

Allison Casey

Allison Casey
According to a study presented at the 2024 ONS Annual Congress, multiple alterations in gut microbial composition and diversity were associated with GI symptoms and breast cancer status.
According to a study presented at the 2024 ONS Annual Congress, multiple alterations in gut microbial composition and diversity were associated with GI symptoms and breast cancer status.
According to a study presented...
04/26/2024
APP Institute Oncology
Conference Coverage
04/26/2024

Amber Denham

Amber Denham
Routine assessment of the core symptoms associated with symptom clusters typical of older patients with cancer warrants consideration, as it may help to provide more targeted and effective symptom management for these patients.
Routine assessment of the core symptoms associated with symptom clusters typical of older patients with cancer warrants consideration, as it may help to provide more targeted and effective symptom management for these patients.
Routine assessment of the core...
04/26/2024
APP Institute Oncology
Conference Coverage
04/25/2024

Stephanie Holland

Stephanie Holland
Use of the Non-Elective Solid Tumor (NEST) Treatment Verification Process enabled oncology nurses to efficiently escalate treatment-related concerns to physicians for patients set to undergo non-elective treatments, according to data...
Use of the Non-Elective Solid Tumor (NEST) Treatment Verification Process enabled oncology nurses to efficiently escalate treatment-related concerns to physicians for patients set to undergo non-elective treatments, according to data...
Use of the Non-Elective Solid...
04/25/2024
APP Institute Oncology
Conference Coverage
04/25/2024

Gina Tomaine

Gina Tomaine
The creation of a standardized screening tool successfully doubled rates of palliative care consult orders and helped identify palliative care needs that arose later in admission to the oncologic ICU.
The creation of a standardized screening tool successfully doubled rates of palliative care consult orders and helped identify palliative care needs that arose later in admission to the oncologic ICU.
The creation of a standardized...
04/25/2024
APP Institute Oncology
Conference Coverage
04/25/2024

Janelle Bradley

Janelle Bradley
Researchers developed a survey, the Oncology Nursing Professional Quality of Life survey, which aims to better measure oncology nurses’ professional quality of life.
Researchers developed a survey, the Oncology Nursing Professional Quality of Life survey, which aims to better measure oncology nurses’ professional quality of life.
Researchers developed a survey,...
04/25/2024
APP Institute Oncology
Conference Coverage
04/25/2024

Allison Casey

Allison Casey
A pilot project found the CASH Assessment Tool was beneficial for holistic communication between RN Navigators and patients during an initial call.
A pilot project found the CASH Assessment Tool was beneficial for holistic communication between RN Navigators and patients during an initial call.
A pilot project found the CASH...
04/25/2024
APP Institute Oncology